Go Pro
OTCMKTS:ATMS

Artemis Therapeutics (ATMS) Stock Price, News & Analysis

Artemis Therapeutics logo

About Artemis Therapeutics Stock (OTCMKTS:ATMS)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
2,942 shs
Market Capitalization
$55.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Artemis Therapeutics, Inc. is a biopharmaceutical company. It develops new treatments for serious and life-threatening infections. It Includes cytomegalovirus and malaria. The company was founded on April 22, 1997 and was headquartered in New York, NY.

Receive ATMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Artemis Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATMS Stock News Headlines

Every Major Market Reset Had These 3 Warning Signs First. All 3 Are Flashing Right Now.
U.S. debt is closing in on 38 trillion as foreign buyers pull back, tightening liquidity across markets. The 2026 Munich Security Report just called the global order Under Destruction, citing trade fragmentation and weakened institutions. Meanwhile, central banks are buying gold at record levels without explanation, and gold has outpaced the S&P 500 in 2026.tc pixel
The Impact Of Utility ATMs On Financial Access
ITRM Iterum Therapeutics plc
See More Headlines

ATMS Stock Analysis - Frequently Asked Questions

Shares of ATMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Artemis Therapeutics investors own include SiteOne Landscape Supply (SITE), Nabriva Therapeutics (NBRV), Meta Platforms (META), Gemini Therapeutics (GMTX), ERYTECH Pharma (ERYP) and

Company Calendar

Today
9/14/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Miscellaneous chemical products
Sub-Industry
Consumer Goods
Current Symbol
OTCMKTS:ATMS
CIK
1062128
Employees
1
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.36 million
Net Margins
-299.54%
Pretax Margin
-299.54%
Return on Equity
N/A
Return on Assets
-425.51%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.15
Quick Ratio
0.12

Sales & Book Value

Annual Sales
$310 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
112,034,000
Free Float
103,687,000
Market Cap
$55.79 million
Optionable
Not Optionable
Beta
-1.92
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:ATMS) was last updated on 9/14/2026 by MarketBeat.com Staff.
From Our Partners